Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line

Poultry Science

Volumn 94, Issue 11, 2015, Pages 2616-2621

  Lian, Ling ^a   Li, Xin ^a   Zhao, Chunfang ^a   Han, Bo ^a   Qu, Lujiang ^a   Song, Jiuzhou ^b   Liu, Changjun ^c   Yang, Ning ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND   (United States)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Chicken; Gga miR 181a; Lymphoma; Marek's disease; MYBL1

Indexed keywords

A-MYB PROTEIN, CHICKEN; AVIAN PROTEIN; MICRORNA; ONCOPROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL; BIRD DISEASE; CELL PROLIFERATION; CHICKEN; GENETICS; MAREK DISEASE; MAREK'S DISEASE VIRUS 1; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VETERINARY; VIROLOGY; WESTERN BLOTTING;

ANIMALS; AVIAN PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHICKENS; HERPESVIRUS 2, GALLID; MAREK DISEASE; MICRORNAS; POULTRY DISEASES; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS;

EID: 84948471084     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps/pev289     Document Type: Article

References (55)

1. Bandres, E., N. Bitarte, F. Arias, J. Agorreta, P. Fortes, X. Agirre, R. Zarate, J. A. Diaz-Gonzalez, N. Ramirez, J. J. Sola, P. Jimenez, J. Rodriguez, and J. Garcia-Foncillas. 2009. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15:2281-2290.
2. Biedenkapp, H., U. Borgmeyer, A. E. Sippel, and K. H. Klempnauer. 1988. Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335:835-837.
3. Brennecke, J., D. R. Hipfner, A. Stark, R. B. Russell, and S. M. Cohen. 2003. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113:25-36.
4. Burgess, S. C., J. R. Young, B. J. Baaten, L. Hunt, L. N. Ross, M. S. Parcells, P. M. Kumar, C. A. Tregaskes, L. F. Lee, and T. F. Davison. 2004. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc Natl Acad Sci U S A 101:13879-13884.
5. Burnside, J., E. Bernberg, A. Anderson, C. Lu, B. C. Meyers, P. J. Green, N. Jain, G. Isaacs, and R. W. Morgan. 2006. Marek's disease virus encodes MicroRNAs that map to meq and the latencyassociated transcript. J Virol 80:8778-8786.
6. Burnside, J., M. Ouyang, A. Anderson, E. Bernberg, C. Lu, B. C. Meyers, P. J. Green, M. Markis, G. Isaacs, E. Huang, and R. W. Morgan. 2008. Deep sequencing of chicken microRNAs. BMC Genomics 9:185.
7. Calin, G. A., and C. M. Croce. 2006. MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866.
8. Calnek, B. W. 1986. Marek's disease-A model for herpesvirus oncology. Crit Rev Microbiol 12:293-320.
9. Calnek, B. W. 2001. Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol 255:25-55.
10. Chen, G., W. Zhu, D. Shi, L. Lv, C. Zhang, P. Liu, and W. Hu. 2010. MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 23:997-1003.
11. Chi, J. Q., M. Teng, Z. H. Yu, H. Xu, J. W. Su, P. Zhao, G. X. Xing, H. D. Liang, R. G. Deng, L. H. Qu, G. P. Zhang, and J. Luo. 2015. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-beta signaling pathway. Virology 476:72-84.
12. Ciafre, S. A., S. Galardi, A. Mangiola, M. Ferracin, C. G. Liu, G. Sabatino, M. Negrini, G. Maira, C. M. Croce, and M. G. Farace. 2005. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351-1358.
13. Dalmay, T. 2008. MicroRNAs and cancer. J Intern Med 263:366-375.
14. Facchinetti, V., L. Loffarelli, S. Schreek, M. Oelgeschlager, B. Luscher, M. Introna, and J. Golay. 1997. Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules. Biochem J 324:729-736.
15. Foos, G., S. Grimm, and K. H. Klempnauer. 1994. The chicken Amyb protein is a transcriptional activator. Oncogene 9:2481-2488.
16. Gao, W., H. Shen, L. Liu, J. Xu, J. Xu, and Y. Shu. 2011. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 137:557-566.
17. Gao, W., Y. Yu, H. Cao, H. Shen, X. Li, S. Pan, and Y. Shu. 2010. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64:399-408.
18. Gartel, A. L., and E. S. Kandel. 2008. miRNAs: Little known mediators of oncogenesis. Semin Cancer Biol 18:103-110.
19. Garzon, R., G. A. Calin, and C. M. Croce. 2009. MicroRNAs in Cancer. Annu Rev Med 60:167-179.
20. Giraldez, A. J., R. M. Cinalli, M. E. Glasner, A. J. Enright, J. M. Thomson, S. Baskerville, S. M. Hammond, D. P. Bartel, and A. F. Schier. 2005. MicroRNAs regulate brain morphogenesis in zebrafish. Science 308:833-838.
21. Golay, J., M. Luppi, S. Songia, C. Palvarini, L. Lombardi, A. Aiello, D. Delia, K. Lam, D. H. Crawford, A. Biondi, T. Barbui, A. Rambaldi, and M. Introna. 1996. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ Bacute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Blood 87:1900-1911.
22. He, Q., X. Zhou, S. Li, Y. Jin, Z. Chen, D. Chen, Y. Cai, Z. Liu, T. Zhao, and A. Wang. 2013. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway. Biochim Biophys Acta 1830:5258-5266.
23. Huang, J. C., T. Babak, T. W. Corson, G. Chua, S. Khan, B. L. Gallie, T. R. Hughes, B. J. Blencowe, B. J. Frey, and Q. D. Morris. 2007. Using expression profiling data to identify human microRNA targets. Nat Methods 4:1045-1049.
24. Jiao, X., L. Zhao, M. Ma, X. Bai, M. He, Y. Yan, Y. Wang, Q. Chen, X. Zhao, M. Zhou, Z. Cui, Z. Zheng, E. Wang, and M. Wei. 2013. MiR-181a enhances drug sensitivity in mitoxantoneresistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Breast Cancer Res Treat 139:717-730.
25. Kaiser, P., G. Underwood, and F. Davison. 2003. Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol 77:762-768.
26. Lambeth, L. S., Y. Yao, L. P. Smith, Y. Zhao, and V. Nair. 2009. MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virustransformed tumour cell line MSB-1. J Gen Virol 90:1164-1171.
27. Lashine, Y. A., A. M. Seoudi, S. Salah, and A. I. Abdelaziz. 2011. Expression signature of microRNA-181-A reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clin Exp Rheumatol 29:351-357.
28. Li, X., L. Lian, D. Zhang, L. Qu, and N. Yang. 2014a. gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation. Poult Sci 93:1097-1105.
29. Li, Z. J., Y. P. Zhang, Y. Li, H. W. Zheng, Y. S. Zheng, and C. J. Liu. 2014b. Distinct expression pattern of miRNAs in Marek's disease virus infected-chicken splenic tumors and non-tumorous spleen tissues. Res Vet Sci 97:156-161.
30. Lian, L., L. J. Qu, J. X. Zheng, C. J. Liu, Y. P. Zhang, Y. M. Chen, G. Y. Xu, and N. Yang. 2010. Expression profiles of genes within a subregion of chicken major histocompatibility complex B in spleen after Marek's disease virus infection. Poult Sci 89:2123-2129.
31. Lian, L., L. Qu, Y. Chen, S. J. Lamont, and N. Yang. 2012. A systematic analysis of miRNA transcriptome in Marek's disease virusinduced lymphoma reveals novel and differentially expressed miRNAs. PLoS One 7:e51003.
32. Luo, J., A. J. Sun, M. Teng, H. Zhou, Z. Z. Cui, L. H. Qu, and G. P. Zhang. 2011. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease. J Gen Virol 92:608-620.
33. Marton, S., M. R. Garcia, C. Robello, H. Persson, F. Trajtenberg, O. Pritsch, C. Rovira, H. Naya, G. Dighiero, and A. Cayota. 2008. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 22:330-338.
34. Motoyama, K., H. Inoue, Y. Takatsuno, F. Tanaka, K. Mimori, H. Uetake, K. Sugihara, and M. Mori. 2009. Over-and underexpressed microRNAs in human colorectal cancer. Int J Oncol 34:1069-1075.
35. Parnas, O., D. L. Corcoran, and B. R. Cullen. 2014. Analysis of the mRNA targetome of microRNAs expressed by Marek's disease virus. MBio 5:e1013-e1060.
36. Payne, L. N., J. A. Frazier, and P. C. Powell. 1976. Pathogenesis of Marek's disease. Int. Rev. Exp. Pathol. 16:59-154.
37. Shi, L., Z. Cheng, J. Zhang, R. Li, P. Zhao, Z. Fu, and Y. You. 2008. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236:185-193.
38. Shin, K. H., S. D. Bae, H. S. Hong, R. H. Kim, M. K. Kang, and N. H. Park. 2011. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem Biophys Res Commun 404:896-902.
39. Sleeman, J. P. 1993. Xenopus A-myb is expressed during early spermatogenesis. Oncogene 8:1931-1941.
40. Stik, G., G. Dambrine, S. Pfeffer, and D. Rasschaert. 2013. The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq. J Virol 87:80-93.
41. Sun, R., X. Fu, Y. Li, Y. Xie, and Y. Mao. 2009. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours. BMC Genomics 10:93.
42. Swartz, C. D., C. A. Afshari, L. Yu, K. E. Hall, and D. Dixon. 2005. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod 11: 441-450.
43. Tian, F., J. Luo, H. Zhang, S. Chang, and J. Song. 2012. MiRNA expression signatures induced by Marek's disease virus infection in chickens. Genomics 99:152-159.
44. Ura, S., M. Honda, T. Yamashita, T. Ueda, H. Takatori, R. Nishino, H. Sunakozaka, Y. Sakai, K. Horimoto, and S. Kaneko. 2009. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49:1098-1112.
45. Valencia-Sanchez, M. A., J. Liu, G. J. Hannon, and R. Parker. 2006. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20:515-524.
46. Wei, Z., L. Cui, Z. Mei, M. Liu, and D. Zhang. 2014. miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway. FEBS Lett 588:1773-1779.
47. Witter, R. L., and K. A. Schat. 2003. Marek's disease. Pages 407-465 in Diseases of poultry, 11th Edition. Y. M. Saif, ed. Wiley-Blackwell, Hoboken.
48. Xu, H., Y. Yao, L. P. Smith, and V. Nair. 2010. MicroRNA-26amediated regulation of interleukin-2 expression in transformed avian lymphocyte lines. Cancer Cell Int 10:15.
49. Yao, Y., Y. Zhao, H. Xu, L. P. Smith, C. H. Lawrie, M. Watson, and V. Nair. 2008. MicroRNA profile of Marek's disease virustransformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol 82:4007-4015.
50. Zamore, P. D., and B. Haley. 2005. Ribo-gnome: The big world of small RNAs. Science 309:1519-1524.
51. Zhang, X., Y. Nie, Du Y, J. Cao, B. Shen, and Y. Li. 2012. MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumour Biol 33:1589-1597.
52. Zhao, P., X. J. Li, M. Teng, L. Dang, Z. H. Yu, J. Q. Chi, J. W. Su, G. P. Zhang, and J. Luo. 2015. In vivo expression patterns of microRNAs of Gallid herpesvirus 2 (GaHV-2) during the virus life cycle and development of Marek's disease lymphomas. Virus Genes 50:245-252.
53. Zhao, Y., H. Xu, Y. Yao, L. P. Smith, L. Kgosana, J. Green, L. Petherbridge, S. J. Baigent, and V. Nair. 2011. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog 7:e1001305.
54. Zhao, Y., Y. Yao, H. Xu, L. Lambeth, L. P. Smith, L. Kgosana, X. Wang, and V. Nair. 2009. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol 83: 489-492.
55. Zhu, Y., J. Wu, S. Li, R. Ma, H. Cao, M. Ji, C. Jing, and J. Tang. 2013. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. Cell Physiol Biochem 32:1225-1237.